FDA Issued Alert for Philips Ultrasound Systems
The FDA warned of software malfunctions in Philips Lumify devices linked to four patient deaths.
Updated on Oct. 14, 2026 in Healthcare
The FDA issued an early alert regarding software malfunctions in Philips Lumify ultrasound systems. Reports indicate the device failures have been linked to four patient deaths.
Why it matters
Unexpected re-registration prompts and unstable USB connections have delayed critical patient care in pre-hospital environments. These issues can render the ultrasound scanners unusable in emergency settings.
Four patient deaths have been reported in connection with diagnostic delays caused by system malfunctions. The company is currently developing a software update to address the re-registration issues.
The players
Food and Drug Administration
The agency is responsible for protecting public health by ensuring the safety and efficacy of medical devices.
Philips
This multinational conglomerate is a prominent manufacturer of medical technology and health systems.
The details
The software issue prevents scanning until a mandatory re-registration process is completed, which requires an active Wi-Fi or cellular signal. Additionally, unstable USB connections between transducers and mobile devices have caused further interruptions to diagnostic capabilities.
Timeline
September 24, 2026: Philips issued a customer letter regarding Lumify usage.
Week of October 14, 2026: The FDA issued an early alert for the system.
Market Landscape
This safety alert highlights the critical nature of software integration in portable medical diagnostics. It forces manufacturers to balance rapid technological deployment with the rigorous safety standards required for point-of-care emergency equipment.
Healthcare providers relying on Lumify systems in field settings must ensure they have access to stable network signals for potential re-registration requirements. Facilities should monitor their device inventory for signs of USB connection instability until a software update is released.
The takeaway
Healthcare teams should verify that their mobile ultrasound equipment is fully registered before heading into areas with limited connectivity. Reliable backups are essential when utilizing software-dependent diagnostic tools in the field.
Further reading
For more on device safety, visit the Healthcare section.
